Alberto Tozzi · Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
Article1 min read·Published Oct 2026

Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Oct 2026 · 1 min read

In brief

In brief

This multicentre trial evaluated long-term hepatitis B immunity in children who received hexavalent vaccines (Hexavac or Infanrix Hexa) during primary immunization, following Hexavac's 2005 suspension due to immunogenicity concerns. The study assessed immune memory persistence and booster response to determine optimal vaccination strategies for sustained protection.

Written by the GCMD Library team from the article.

Alberto Tozzi

In 2000, hexavac and infanrix hexa were licensed in Europe for primary immunisation of children against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive infections caused by Haemophilus influenzae b. In 2005, hexavac was suspended because of concerns about the long-term immunogenicity of its hepatitis B component. We aimed to assess the duration of immunity and need for boo…

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →